Rafael Pharmaceuticals Enters into Collaboration with the National Institutes of Health (NIH) to Test CPI-613® (devimistat) in Cytokine Independent (Acute) HTLV-1 Associated Adult T-cell Leukemia/Lymphoma

Paul Theisen
Patient Acquisition

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement

Frank Burrell
Scientific Storytelling

David Linetsky
Point-of-Care Marketing

Bud Bilanich
Success Coach